Osteoblastic Metastasis from Breast Cancer

  • Rajesh GuptaEmail author


Osteoblastic or sclerotic bone metastases most commonly arise in prostate and breast cancer. PET/MR imaging is useful in detecting low signal sclerotic marrow involvement, even when their metabolic activity may be minimal.


Osteoblastic bone metastases Sclerotic bone metastases PET/MR FDG Breast cancer Prostate cancer 

Suggested Reading

  1. Cook GJ, Houston S, Rubens R, Maisey MN, Fogelman I. Detection of bone metastases in breast cancer by 18FDG PET: differing metabolic activity in osteoblastic and osteolytic lesions. J Clin Oncol. 1998;16(10):3375–9.CrossRefPubMedGoogle Scholar
  2. O’Sullivan GJ, Carty FL, Cronin CG. Imaging of bone metastasis: an update. World J Radiol. 2015;7(8):202–11.CrossRefPubMedPubMedCentralGoogle Scholar

Copyright information

© Springer International Publishing AG 2018

Authors and Affiliations

  1. 1.Department of RadiologyStony Brook University HospitalStony BrookUSA

Personalised recommendations